Adenosine phosphonate inhibitors of lipid II: alanyl tRNA ligase MurM from Streptococcus pneumoniae

Elena Cressina1, Adrian J Lloyd, Gianfranco De Pascale

  • 1Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK.

Insights

Researchers developed novel inhibitors targeting MurMN/FemABX enzymes, crucial for high-level penicillin resistance in gram-positive bacteria. These phosphonate transition state analogues represent a significant advancement in combating antibiotic resistance.

Area of Science:

  • Biochemistry
  • Microbiology
  • Medicinal Chemistry

Background:

  • High-level penicillin resistance in gram-positive bacteria poses a significant threat to public health.
  • The MurMN/FemABX enzyme family plays a critical role in peptidoglycan biosynthesis, a target for antibiotics.
  • Understanding resistance mechanisms is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To identify and characterize inhibitors of the MurMN/FemABX family of tRNA-dependent ligases.
  • To explore novel therapeutic approaches against penicillin-resistant gram-positive bacteria.

Main Methods:

  • Synthesis of adenosine and 2'-deoxyadenosine phosphonate transition state analogues.
  • Biochemical assays to evaluate inhibitory activity against MurMN/FemABX ligases.
  • Characterization of enzyme kinetics and inhibition mechanisms.

Main Results:

  • Adenosine and 2'-deoxyadenosine phosphonate transition state analogues were identified as potent inhibitors.
  • These compounds represent the first reported inhibitors for the MurMN/FemABX enzyme family.
  • The inhibitors effectively target a key step in peptidoglycan synthesis essential for bacterial survival.

Conclusions:

  • The developed phosphonate analogues are promising lead compounds for novel antibiotics.
  • Targeting MurMN/FemABX ligases offers a viable strategy to overcome high-level penicillin resistance.
  • Further research is warranted to develop these inhibitors into clinically effective drugs.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...